Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunotherapy
>>
Phase 3
«
1
2
...
3
4
5
6
7
8
9
10
11
12
13
14
15
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
33
66
99
132
165
198
231
264
297
330
Qingshu-Yiqi-Tang
/ Chuang Song Zong Pharma
Quellor
(DN-TNF) / INmune Bio
RGB-14-P
(denosumab biosimilar) / Gedeon Richter
Retuxira
(rituximab biosimilar) / 3SBio
RituxiRel
(rituximab biosimilar) / Reliance Life Sci, Torrent Pharma
S-268019
/ Shionogi
SARS-CoV-2 convalescent plasma
/ French Defence Health Service Headquarters
SIBP-02
(rituximab biosimilar) / Sinopharm
Sulinno
(adalimumab biosimilar) / Innovent Biologics
Td-Impfstoff Merieux
/ Sanofi
Venoglobulin-S
(human immune globulin intravenous) / Grifols
Verity-BCG
(Strain Russian BCG-I) / Verity Pharma
Virulizin
(bovine bile tissue extract) / Aptose Biosci, Zoticon Bioventures
Xacrel
(ocrelizumab biosimilar) / CinnaGen
Yusimry
(adalimumab-aqvh) / Nanjing King-Friend Bio
Zerun HPV-9
/ Walvax
convalescent anti-SARS-CoV-2 plasma
/ Hvidovre Hospital
diphtheria, tetanus and pertussis combined vaccine
(DTacP booster) / Sinopharm
high titer convalescent COVID 19 plasma
(HT-CCP) / Brigham and Womens Hospital
human immune globulin IV 10%
(IVIG) / Liminal BioSci
human immunoglobulin G IV
(GC5101B) / GC Biopharma
inactivated COVID-19 vaccine
(Omicron variant) / Sinovac
infliximab oral
(CT-P13 oral) / Intract Pharma, Celltrion
lipid disorder vaccine
/ VLP Biotech
lyophilised bacterical lysate
/ Generic mfg.
pathogen reduced SARS-CoV-2 convalescent plasma
/ Vanderbilt University Medical Center
plasma-derived immunoglobulin-enriched solution
/ Ahvaz Jundishapur University of Medical Sciences
rovaleucel
(TT10) / Tessa Therap
seviprotimut-L
(POL-103A) / CK Life Sci
tabirafusp tedromer
(KSI-501) / Kodiak Sciences
«
1
2
...
3
4
5
6
7
8
9
10
11
12
13
14
15
